Skip to content
AnalystLens

CHURCH & DWIGHT CO INC /DE/ Quarterly Report for Q3 Ended Sep 30, 2024

Filing Date
Filed November 1, 2024
Period End
September 30, 2024
Security
CHD
In the record · 2016–202610-K1110-Q328-K103

CHD filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 103 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Mar ’18Mar ’18
  2. Leadership change8-K · Apr ’21Apr ’21
  3. Leadership change8-K · May ’23May ’23

Summary

Summary of the 10-Q filed November 1, 2024. Cited figures are marked; the original filing is the authoritative source.

Church & Dwight Co., Inc. (CHD) reported a net loss of $75.1 milliona for the third quarter of 2024, a significant shift from the $177.5 million net income in the prior year.

This downturn was primarily driven by a substantial $357.1 millionb non-cash impairment charge related to the Vitamins, Minerals, and Supplements (VMS) business, impacting goodwill and other intangible assets. Despite this, the company saw a 3.8% increase in net sales to $1,510.6 million, with growth in both the Consumer Domestic and Consumer International segments, indicating underlying demand for its core products. Operationally, the company managed to improve its gross margin by 80 basis points to 45.2% due to productivity gains and favorable pricing, partially offset by higher manufacturing costs.

Marketing expenses increased to support new product introductions. The company maintained a strong liquidity position with $752.1 millionc in cash and cash equivalents and significant availability under its revolving credit facility.

The impairment charge significantly impacted operating income and EPS, resulting in a diluted loss per share of $0.31d for the quarter. Management is focusing on integrating recent acquisitions and managing costs while navigating a competitive market landscape.

Key Highlights

  1. Third-quarter net loss of $75.1 million due to a $357.1 million impairment charge on VMS assets, contrasting with a $177.5 million profit in Q3 2023.
  2. Net sales increased by 3.8% to $1,510.6 million in the third quarter, driven by volume and favorable pricing/mix across segments.
  3. Gross margin improved by 80 basis points to 45.2% due to productivity initiatives and price/volume/mix, despite higher manufacturing costs.
  4. Marketing expenses rose 10.7% to support new product launches, impacting operating expenses.
  5. The company acquired Graphico for $19.9 million, expanding its presence in the Asia-Pacific region.
  6. Liquidity remains strong with $752.1 million in cash and cash equivalents and substantial credit facility availability.
  7. Diluted EPS turned negative at $(0.31) for the quarter, primarily due to the significant impairment charge.

Follow one dollar

For each $1.00 of revenue in Q3 FY2024, Church & Dwight Co Inc lost $0.05.

  1. Revenue$1.51B100.0%
  2. Cost of revenue−$827.5M54.8%
  3. Gross profit$683.1M45.2%
  4. Operating costs−$774.6M51.3%
  5. Operating income−$91.5M6.1%
  6. Interest, other & tax$16.4M1.1%
  7. Net income−$75.1M5.0%
Computed from 10-QQ3 FY2024filed November 1, 2024Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

Q3 FY2024 against Q3 FY2023

Line itemQ3 FY2024Q3 FY2023Change
Revenue$1.51B$1.46B+3.8%
Cost of Revenue$827.50M$809.60M+2.2%
Gross Profit$683.10M$646.30M+5.7%
R&D Expenses$36.00M$30.30M+18.8%
SG&A Expenses$231.70M$222.70M+4.0%
Operating Income-$91.50M$255.80M−135.8%
Interest Expense$23.40M$27.20M−14.0%
Net Income-$75.10M$177.50M−142.3%
EPS (Basic)$-0.31$0.72−143.1%
EPS (Diluted)$-0.31$0.71−143.7%
Shares Outstanding (Basic)244.60M246.00M−0.6%
Shares Outstanding (Diluted)244.60M248.70M−1.6%

Frequently Asked Questions

  1. What caused the significant net loss in the third quarter of 2024?

    The net loss of $75.1 million was primarily caused by a substantial $357.1 million non-cash impairment charge recognized in the third quarter. This charge related to the decline in market share and financial performance of the Vitamins, Minerals, and Supplements (VMS) business, impacting intangible assets like trade names and customer relationships, as well as related property, plant, and equipment.

  2. How did the company's sales perform in the third quarter, excluding the impact of the impairment?

    Excluding the impact of the impairment charge, the company's sales showed resilience. Net sales increased by 3.8% to $1,510.6 million, driven by a 3.1% increase in product volumes and a 1.2% favorable impact from pricing and product mix. Growth was observed in both the Consumer Domestic and Consumer International segments.

  3. What is the financial outlook for the VMS business following the impairment charge?

    The impairment charge reflects a reassessment of the long-term strategy and financial outlook for the VMS business due to significant competition and declining market share. The revised outlook indicates lower estimated future sales growth and cash flows, suggesting continued challenges for this segment. Management is focused on growth and profitability initiatives, but the impairment highlights a significant underperformance.

  4. How is the company managing its liquidity and debt levels?

    The company maintains a strong liquidity position with $752.1 million in cash and cash equivalents as of September 30, 2024. It also has approximately $1,495.0 million available under its revolving credit facility and commercial paper program. Debt levels have decreased due to the repayment of a $200.0 million term loan in the first quarter of 2024, and the company anticipates sufficient cash from operations and borrowing capacity to meet its financial obligations, including dividends and capital expenditures.